Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT06280196
What this trial is testing

Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bio-Thera Solutions 162
Testing effectiveness (Phase 2)UnknownNCT03703596
What this trial is testing

Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC

Who this might be right for
Lung CancerLung Cancer Metastatic
Sichuan Cancer Hospital and Research Institute 88
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Early research (Phase 1)Ended earlyNCT06091930
What this trial is testing

Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

Who this might be right for
Gastrointestinal CancerLung CancerPancreatic Cancer+3 more
Boehringer Ingelheim 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07831863
What this trial is testing

7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy

Who this might be right for
Lung Squamous Cell Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd. 600
Early research (Phase 1)Ended earlyNCT04870112
What this trial is testing

Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung Cancer
AstraZeneca 18
Not applicableEnrolling By InvitationNCT07373951
What this trial is testing

Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Ming Yang 380
Not applicableUnknownNCT05925751
What this trial is testing

Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNeoadjuvant ChemoimmunotherapyComplete Pathological Response
Shanghai Pulmonary Hospital, Shanghai, China 100
Testing effectiveness (Phase 2)WithdrawnNCT02109653
What this trial is testing

Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Array Biopharma, now a wholly owned subsidiary of Pfizer
Large-scale testing (Phase 3)UnknownNCT04535739
What this trial is testing

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 414
Not applicableEnrolling By InvitationNCT07307157
What this trial is testing

Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review

Who this might be right for
Brain CancerLung Cancer (Diagnosis)Renal Cancer
Harvard Medical School (HMS and HSDM) 30
Post-approval studies (Phase 4)Study completedNCT02805166
What this trial is testing

PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

Who this might be right for
Malignant Solid Tumors
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 420
Testing effectiveness (Phase 2)Active Not RecruitingNCT05712902
What this trial is testing

Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)

Who this might be right for
Non-Small Cell Lung Cancer
Dizal Pharmaceuticals 104
Testing effectiveness (Phase 2)Temporarily pausedNCT01627795
What this trial is testing

Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment

Who this might be right for
Mesothelioma
Oshadi Drug Administration 17
Testing effectiveness (Phase 2)UnknownNCT05394233
What this trial is testing

Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC

Who this might be right for
Non-squamous Non-small Cell Lung CancerEGFR Gene Mutation
Sichuan Cancer Hospital and Research Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT04032847
What this trial is testing

ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC

Who this might be right for
Advanced Non Small Cell Lung Cancer
Achilles Therapeutics UK Limited 27
Post-approval studies (Phase 4)Study completedNCT03607149
What this trial is testing

Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies

Who this might be right for
Non-small Cell Lung Cancer
Centre Georges Francois Leclerc 11
Large-scale testing (Phase 3)Ended earlyNCT02134015
What this trial is testing

Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
Daiichi Sankyo 145
Not applicableNot Yet RecruitingNCT05745506
What this trial is testing

Effect of Sleep Disorder on the Development of Lung Tumors

Who this might be right for
Sleep Disorder, Lung Tumor
RenJi Hospital 200
Testing effectiveness (Phase 2)UnknownNCT04840758
What this trial is testing

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

Who this might be right for
Multiple Primary Lung Cancer
The First Affiliated Hospital of Xiamen University 39
Next Page